Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Clinical Trial Needs Clarified By ISO Standard, Ongoing MDD Review

This article was originally published in The Gray Sheet

Executive Summary

ISO 14155, a new draft standard addressing the investigation of medical devices in human subjects, is nearing completion

You may also be interested in...



Device Type Reclassification Urged As Alternative To EU Implant Proposal

European member states should exercise their option to reclassify specific product types as an alternative to the wholesale reclassification of implants from Class IIb to Class III, EUCOMED maintains.

International Clinical Data Reporting Standards Await GHTF Review

Clinical data requirements for manufacturers making performance and safety claims for high-risk devices will be considered by the Global Harmonization Task Force in response to the Medical Device Directive's (MDD) five-year review, according to UK Medical Device Agency Director David Jefferys.

Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children

Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016043

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel